Therapeutic Strategies With Selective CDK4/6 Inhibitors: An Oncologist’s Guide to Safe Inhibition of Uncontrolled Cellular Proliferation in Solid Tumors
  • Program Overview
    Therapeutic Strategies With Selective CDK4/6 Inhibitors: An Oncologist’s Guide to Safe Inhibition of Uncontrolled Cellular Proliferation in Solid Tumors
    Review recent developments with selective CDK4/6 inhibitors in the care of patients with various cancers in this certified text module, on-demand Webcast, and accompanying slideset developed by Richard Finn, MD; Geoffrey Shapiro, MD, PhD; and Gary K. Schwartz, MD.
  • Featured content
    Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, discuss the supporting rationale and emerging role of selective CDK4/6 inhibitors in multiple types of cancer.
  • 1
  • 2

Latest Content

2 of 2 Shown
2 of 2 Shown
Show 0 More
Loading...